signNow supports requesting and collecting payments during document-signing workflows.
RevManicRevenue Stack
Part of airSlate
Electronic signature and document workflow automation platform.
Revenue footprint
signNow supports requesting and collecting payments during document-signing workflows.
signNow enables users to prepare documents, assign signer roles and order, send signature requests, collect electronic signatures, and retain completed documents with audit trails.
Overview
signNow enables users and businesses to create, send, sign, and manage legally binding documents, with templates, multi-step signing, audit trails, authentication, forms, mobile apps, and API capabilities.
Buying context
Pricing
Official signNow information publishes annual per-user prices for Business, Business Premium, and Enterprise, a usage-based Site License price, and airSlate Business Cloud pricing. The official pricing page is the purchase entry point; the reviewed official information page provides the numeric plan details.
Published as $8/user/month billed annually; no credit card required for the trial.
Check current price ↗Published as $15/user/month billed annually; no credit card required for the trial.
Check current price ↗Published as $30/user/month billed annually; no credit card required for the trial.
Check current price ↗Published as $50/user/month billed annually; includes signNow, airSlate, pdfFiller, and US Legal Forms.
Check current price ↗$1.50 per signature invite; intended for organizations sending 1,000+ documents per year; unlimited users. SSO, full API, phone support, HIPAA, 21 CFR Part 11, and QES are described as add-ons or plan-dependent.
Check current price ↗List prices can exclude tax, usage charges, onboarding, add-ons, and negotiated discounts. Check the vendor page before buying.
Reviews
RevManic has not ingested a verified review source for this product yet. We do not convert vendor testimonials into star ratings.
Suggest a review sourceWe reviewed these official vendor documents. Product claims have not yet been independently tested.